Home/Investors/Casdin Capital

Casdin Capital

Biotech Investor · 6 portfolio companies

Portfolio

6

Focus Areas

9

Top Stage

preclinical

Investment Focus

Oncology Genetics & Genomics Cardiovascular Fibrosis Infectious Disease Respiratory Diseases Autoimmune Diseases Inflammatory Diseases Immunology

Portfolio Companies

Company	Stage	Valuation	Focus
Volastra Therapeutics	preclinical	—	Oncology, Genetics & Genomics
Haya Therapeutics	preclinical	—	Cardiovascular, Fibrosis
Leyden Labs	Phase 1	—	Infectious Disease, Respiratory Diseases
Sonoma Biotherapeutics	Phase 1	—	Autoimmune Diseases, Inflammatory Diseases
IDRx, Inc.	phase-1	—	Oncology
Clasp Therapeutics	preclinical	—	Oncology, Immunology

Frequent Co-Investors

GV3 shared Frazier Life Sciences1 shared Atlas Venture1 shared ARCH Venture Partners1 shared Alexandria Venture Investments1 shared 8VC1 shared Droia Ventures1 shared Vertex Ventures HC1 shared